Literature DB >> 19749437

Galanin fiber hyperinnervation preserves neuroprotective gene expression in cholinergic basal forebrain neurons in Alzheimer's disease.

Scott E Counts1, Bin He, Shaoli Che, Stephen D Ginsberg, Elliott J Mufson.   

Abstract

Fibers containing galanin (GAL) hyperinnervate cholinergic basal forebrain (CBF) nucleus basalis neurons in late stage Alzheimer's disease (AD), yet the molecular consequences of this phenomenon are unknown. To determine whether GAL alters the expression of genes critical to CBF cell survival in AD, single cell microarray analysis was used to determine mRNA levels within nucleus basalis neurons lacking GAL innervation from subjects who died with a clinical diagnosis of no cognitive impairment (NCI) compared to nucleus basalis neurons from AD cases either lacking GAL hyperinnervation (AD/GAL-) or those displaying prominent GAL hyperinnervation (AD/GAL+). Levels of mRNAs encoding putatively neuroprotective proteins such as the GluR2 Ca(2)-impermeable glutamate receptor subunit, superoxide dismutase 2, and the GLUT2 glucose transporter were significantly decreased in AD/GAL- nucleus basalis neurons compared to NCI and AD/GAL+ neurons. By contrast, mRNAs encoding calpain catalytic and regulatory subunits, which may contribute to cell death in AD, were increased in AD/GAL- compared to NCI and AD/GAL+ neurons. Hence, GAL fiber hyperinnervation appears to preserve the expression of genes subserving multiple neuroprotective pathways suggesting that GAL overexpression regulates CBF neuron survival in AD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19749437      PMCID: PMC2884383          DOI: 10.3233/JAD-2009-1196

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  81 in total

1.  Increased expression of estrogen receptor alpha and beta in the nucleus basalis of Meynert in Alzheimer's disease.

Authors:  T A Ishunina; D F Swaab
Journal:  Neurobiol Aging       Date:  2001 May-Jun       Impact factor: 4.673

Review 2.  The control of neuronal Ca2+ homeostasis.

Authors:  R J Miller
Journal:  Prog Neurobiol       Date:  1991       Impact factor: 11.685

3.  Transcriptional profiling of small samples in the central nervous system.

Authors:  Stephen D Ginsberg
Journal:  Methods Mol Biol       Date:  2008

4.  Galanin blocks the slow cholinergic EPSP in CA1 pyramidal neurons from ventral hippocampus.

Authors:  P Dutar; Y Lamour; R A Nicoll
Journal:  Eur J Pharmacol       Date:  1989-05-19       Impact factor: 4.432

5.  Selective loss of central cholinergic neurons in Alzheimer's disease.

Authors:  P Davies; A J Maloney
Journal:  Lancet       Date:  1976-12-25       Impact factor: 79.321

6.  Loss of calbindin-D28k from aging human cholinergic basal forebrain: relation to neuronal loss.

Authors:  Changiz Geula; Jing Bu; Nicholas Nagykery; Leonard F M Scinto; Jennifer Chan; Jeffrey Joseph; Robert Parker; Chuang-Kuo Wu
Journal:  J Comp Neurol       Date:  2003-01-06       Impact factor: 3.215

7.  Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment.

Authors:  Steven T DeKosky; Milos D Ikonomovic; Scot D Styren; Laurel Beckett; Stephen Wisniewski; David A Bennett; Elizabeth J Cochran; Jeffrey H Kordower; Elliott J Mufson
Journal:  Ann Neurol       Date:  2002-02       Impact factor: 10.422

8.  Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases.

Authors:  Joungil Choi; Allan I Levey; Susan T Weintraub; Howard D Rees; Marla Gearing; Lih-Shen Chin; Lian Li
Journal:  J Biol Chem       Date:  2004-01-13       Impact factor: 5.157

Review 9.  Glucose metabolism and insulin receptor signal transduction in Alzheimer disease.

Authors:  Siegfried Hoyer
Journal:  Eur J Pharmacol       Date:  2004-04-19       Impact factor: 4.432

Review 10.  Functional genomic methodologies.

Authors:  Stephen D Ginsberg; Károly Mirnics
Journal:  Prog Brain Res       Date:  2006       Impact factor: 2.453

View more
  23 in total

1.  Expression profiling of precuneus layer III cathepsin D-immunopositive pyramidal neurons in mild cognitive impairment and Alzheimer's disease: Evidence for neuronal signaling vulnerability.

Authors:  Bin He; Sylvia E Perez; Sang H Lee; Stephen D Ginsberg; Michael Malek-Ahmadi; Elliott J Mufson
Journal:  J Comp Neurol       Date:  2020-05-05       Impact factor: 3.215

2.  Gene expression levels assessed by CA1 pyramidal neuron and regional hippocampal dissections in Alzheimer's disease.

Authors:  Stephen D Ginsberg; Melissa J Alldred; Shaoli Che
Journal:  Neurobiol Dis       Date:  2011-07-28       Impact factor: 5.996

Review 3.  Hippocampal plasticity during the progression of Alzheimer's disease.

Authors:  E J Mufson; L Mahady; D Waters; S E Counts; S E Perez; S T DeKosky; S D Ginsberg; M D Ikonomovic; S W Scheff; L I Binder
Journal:  Neuroscience       Date:  2015-03-12       Impact factor: 3.590

4.  Local cholinergic-GABAergic circuitry within the basal forebrain is modulated by galanin.

Authors:  Joanne C Damborsky; Kathleen G Smith; Patricia Jensen; Jerrel L Yakel
Journal:  Brain Struct Funct       Date:  2016-08-05       Impact factor: 3.270

5.  Protein homeostasis gene dysregulation in pretangle-bearing nucleus basalis neurons during the progression of Alzheimer's disease.

Authors:  Chelsea T Tiernan; Stephen D Ginsberg; Angela L Guillozet-Bongaarts; Sarah M Ward; Bin He; Nicholas M Kanaan; Elliott J Mufson; Lester I Binder; Scott E Counts
Journal:  Neurobiol Aging       Date:  2016-03-08       Impact factor: 4.673

6.  Expression profiling suggests microglial impairment in human immunodeficiency virus neuropathogenesis.

Authors:  Stephen D Ginsberg; Melissa J Alldred; Satya M Gunnam; Consuelo Schiroli; Sang Han Lee; Susan Morgello; Tracy Fischer
Journal:  Ann Neurol       Date:  2018-02-10       Impact factor: 10.422

7.  Synaptic gene dysregulation within hippocampal CA1 pyramidal neurons in mild cognitive impairment.

Authors:  Scott E Counts; Melissa J Alldred; Shaoli Che; Stephen D Ginsberg; Elliott J Mufson
Journal:  Neuropharmacology       Date:  2013-10-25       Impact factor: 5.250

8.  Maternal Choline Supplementation Alters Basal Forebrain Cholinergic Neuron Gene Expression in the Ts65Dn Mouse Model of Down Syndrome.

Authors:  Christy M Kelley; Stephen D Ginsberg; Melissa J Alldred; Barbara J Strupp; Elliott J Mufson
Journal:  Dev Neurobiol       Date:  2019-06-09       Impact factor: 3.964

9.  An assembly of galanin-galanin receptor signaling network.

Authors:  Lathika Gopalakrishnan; Oishi Chatterjee; Chinmayi Raj; Deepshika Pullimamidi; Jayshree Advani; Anita Mahadevan; T S Keshava Prasad
Journal:  J Cell Commun Signal       Date:  2020-11-02       Impact factor: 5.782

10.  Long-term effects of maternal choline supplementation on CA1 pyramidal neuron gene expression in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease.

Authors:  Melissa J Alldred; Helen M Chao; Sang Han Lee; Judah Beilin; Brian E Powers; Eva Petkova; Barbara J Strupp; Stephen D Ginsberg
Journal:  FASEB J       Date:  2019-06-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.